With all major US export-oriented drug manufacturing plants in the country up for inspection in 2022, some estimates peg that at least 20-30 per cent of the new product launches lined up for the US will be subject to on-site inspection by the US Food and Drug Administration (USFDA). The last two years saw limited physical inspections due to travel restrictions during the pandemic. "Pre-Covid, the frequency and number of inspections of manufacturing plants in India by USFDA had increased significantly," analysts from ICICI Securities Research noted. "With growing ANDA filings, especially for complex products. "We expect this trend to return with the environment normalising," analysts from ICICI Securities Research noted.
The 30-share Sensex ended down 32 points at 28,851 and the 50-share Nifty closed 12 points lower at 8,712.
Mixed global cues and decline in crude oil prices further dent the sentiments.
The S&P BSE Midcap and the S&P BSE Smallcap indices under-performed to lose 0.8% and 1.6%
Sensex, Nifty put up a good show in closing trade.
Sentiment also remained buoyant as a good monsoon season lifted hopes of a revival in farm output.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Life in Telangana is likely to come to a standstill on Tuesday, thanks to the state government's Intensive Household Survey. Not just the state-owned public transport buses, even private vehicles, will remain off the roads.
Ajit Mishra, vice president, research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Broader markers outperformed their larger peers.
An expectation of tax sops in Budget, weakness of dollar and robust tax collection are adding positive sentiment
Short-covering and the propping up of net asset values have potential to boost frontline as well as second-rung names next week
The Sensex ended below 28,000 for the second straight day at 27,869.
Rise in investor sentiment, return of risk appetite aid shares across the board
The Nifty had hit its third successive record high of 7,922.70 today.
Rate-sensitive sectors like banks, auto and realty witnessed strong buying demand in trades today
Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.
Big bull's holdings cross Rs 7,200 crore (Rs 72 billion).
FPIs sold shares worth a net Rs 1236.95 crore on Friday.
Leading IT companies i-flex Software and Satyam Computers have made their way to Forbes Global's list of 100 'best under a billion' companies in Asia Pacific.
Investors turn their attention to export-driven sectors.
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
In a big shot in the arm for the YSR Congress party in Andhra Pradesh, a Central Bureau of Investigation court in Hyderabad on Monday granted conditional bail to its president and Member of Lok Sabha YS Jaganmohan Reddy in disproportionate assets case.
Market breadth continued to remain strong, with 1899 gainers and 674 losers on the BSEs.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries
Large and small businesses alike have delivered low-key performances.
AstraZeneca on Wednesday announced that it had filed separate patent infringement actions in the United States District Court, Delaware, against seven generic drug manufacturers, which have submitted abbreviated new drug applications (ANDAs) with the US Food and Drug Administration (FDA) seeking marketing authorisation for Crestor.
This increase is despite the decreased growth of drug sales in the US - the world's largest market - which has seen a tightening of regulations and aggressive competition.
The WPI inflation stood at negative 2.4% in May 2015, compared with a negative 2.65% in April 2015.
Audit firms such as KPMG believe zero complaints may be an indicator of the lack of requisite mechanism to allow for such reporting
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Markets in green tracking firm global cues.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The rally in index heavyweight ITC has boosted the sentiment across the board.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The policy statement by the RBI governor is also expected to be upbeat.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances